Wikidata entity: Q64348927
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 226 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2014-10-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P131 | located in the administrative territorial entity | ... | Q1183 (Puerto Rico) | Puerto Rico |
| P6153 | research site | ... | Q1433199 (Indiana University – Purdue University Indianapolis) | Indiana University – Purdue University Indianapolis |
| P6153 | research site | ... | Q7733638 (The Feinstein Institute for Medical Research) | The Feinstein Institute for Medical Research |
| P6153 | research site | ... | Q30269584 (Altoona Center for Clinical Research) | Altoona Center for Clinical Research |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P580 | start time | ... | 2014-01-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02041091 |
Why not click here or view trends?
log id: 4764294